Breaking News Instant updates and real-time market news.

NSANY

Nissan

$0.00 /

+ (+0.00%)

, RNSDF

Renault

$0.00 /

+ (+0.00%)

19:29
04/18/19
04/18
19:29
04/18/19
19:29

Nissan to cut global output by 15% in FY19/20, Nikkei reports

Nissan Motor (NSANY) will reduce its global output by about 15% in the fiscal year ending March of 2020 to 4.6M cars, which would be its lowest in 9 years, Nikkei Asian Review's Natsuki Yamamoto reports, citing "plans communicated to suppliers". The report notes that that company is prioritizing profitability over sales volume, and that its production cut could impact its alliance with Renault (RNSDF). Reference Link

NSANY

Nissan

$0.00 /

+ (+0.00%)

RNSDF

Renault

$0.00 /

+ (+0.00%)

NSANY Nissan
$0.00 /

+ (+0.00%)

04/03/19 BMO Capital
March U.S. auto sales mix negative for Magna, says BMO Capital
11/23/18 Macquarie
Nissan downgraded to Neutral from Outperform at Macquarie
11/23/18 Jefferies
Renault upgraded to Buy from Hold at Jefferies
RNSDF Renault
$0.00 /

+ (+0.00%)

10/15/18 UBS
Renault downgraded to Neutral from Buy at UBS

TODAY'S FREE FLY STORIES

Hot Stocks
Papa John's sees July Systemwide North America restaurants SSS up 30.3% » 06:35
08/06/20
08/06
06:35
08/06/20
06:35
PZZA

Papa John's

$99.32 /

+1.65 (+1.69%)

Sees July System-wide…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PZZA Papa John's
$99.32 /

+1.65 (+1.69%)

PZZA Papa John's
$99.32 /

+1.65 (+1.69%)

07/27/20 Stephens
McDonald's, Domino's among restaurant stocks to own now, says Stephens
07/27/20 Longbow
Papa John's U.S. comps up high-teens percentage in recent weeks, says Longbow
07/01/20
Fly Intel: Top five analyst initiations
07/01/20 Wedbush
Wedbush bullish on Papa John's, initiates with an Outperform
PZZA Papa John's
$99.32 /

+1.65 (+1.69%)

PZZA Papa John's
$99.32 /

+1.65 (+1.69%)

PZZA Papa John's
$99.32 /

+1.65 (+1.69%)

Recommendations
Mallinckrodt price target lowered to $1 from $2 at Citi » 06:34
08/06/20
08/06
06:34
08/06/20
06:34
MNK

Mallinckrodt

$1.54 /

-0.08 (-4.94%)

Citi analyst Navann Ty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNK Mallinckrodt
$1.54 /

-0.08 (-4.94%)

MNK Mallinckrodt
$1.54 /

-0.08 (-4.94%)

08/05/20 BMO Capital
Mallinckrodt price target lowered to $2 from $4 at BMO Capital
08/04/20 Piper Sandler
Mallinckrodt downgraded to Underweight from Neutral at Piper Sandler
07/14/20 BMO Capital
Briefing docs suggest AdComm 'challenges' for Mallinckrodt, says BMO Capital
06/17/20 Citi
Sell Mallinckrodt, buy Endo with opioid risk coming back, says Citi
MNK Mallinckrodt
$1.54 /

-0.08 (-4.94%)

MNK Mallinckrodt
$1.54 /

-0.08 (-4.94%)

MNK Mallinckrodt
$1.54 /

-0.08 (-4.94%)

MNK Mallinckrodt
$1.54 /

-0.08 (-4.94%)

Hot Stocks
Quarterhill subsidiaries grant patent license to Kingston Technology » 06:33
08/06/20
08/06
06:33
08/06/20
06:33
QTRH

Quarterhill

$0.00 /

+ (+0.00%)

Wi-LAN, a Quarterhill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QTRH Quarterhill
$0.00 /

+ (+0.00%)

Earnings
Restaurant Brands reports Q2 adj. EPS 33c, consensus 56c » 06:33
08/06/20
08/06
06:33
08/06/20
06:33
QSR

Restaurant Brands

$57.64 /

-0.255 (-0.44%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QSR Restaurant Brands
$57.64 /

-0.255 (-0.44%)

QSR Restaurant Brands
$57.64 /

-0.255 (-0.44%)

08/04/20 RBC Capital
Restaurant Brands price target raised to $63 from $57 at RBC Capital
06/30/20 SunTrust
Restaurant Brands price target raised to $63 from $60 at SunTrust
05/18/20 Standpoint Research
Restaurant Brands initiated with a Buy at Standpoint Research
05/15/20
Fly Intel: Top five analyst upgrades
QSR Restaurant Brands
$57.64 /

-0.255 (-0.44%)

  • 04
    Sep
  • 09
    Aug
QSR Restaurant Brands
$57.64 /

-0.255 (-0.44%)

QSR Restaurant Brands
$57.64 /

-0.255 (-0.44%)

Hot Stocks
National Vision sees FY20 CapEx $65M-$75M » 06:33
08/06/20
08/06
06:33
08/06/20
06:33
EYE

National Vision

$34.02 /

+0.34 (+1.01%)

Sees incremental COVID-19…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EYE National Vision
$34.02 /

+0.34 (+1.01%)

EYE National Vision
$34.02 /

+0.34 (+1.01%)

06/10/20 Citi
National Vision price target raised to $36 from $31 at Citi
06/09/20 Wells Fargo
National Vision price target raised to $36 from $28 at Wells Fargo
05/08/20 Guggenheim
National Vision price target lowered to $35 from $45 at Guggenheim
04/17/20 Barclays
National Vision price target lowered to $28 from $44 at Barclays
EYE National Vision
$34.02 /

+0.34 (+1.01%)

  • 08
    Aug
EYE National Vision
$34.02 /

+0.34 (+1.01%)

Earnings
Papa John's reports Q2 EPS 48c, consensus 45c » 06:33
08/06/20
08/06
06:33
08/06/20
06:33
PZZA

Papa John's

$99.32 /

+1.65 (+1.69%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PZZA Papa John's
$99.32 /

+1.65 (+1.69%)

PZZA Papa John's
$99.32 /

+1.65 (+1.69%)

07/27/20 Stephens
McDonald's, Domino's among restaurant stocks to own now, says Stephens
07/27/20 Longbow
Papa John's U.S. comps up high-teens percentage in recent weeks, says Longbow
07/01/20
Fly Intel: Top five analyst initiations
07/01/20 Wedbush
Wedbush bullish on Papa John's, initiates with an Outperform
PZZA Papa John's
$99.32 /

+1.65 (+1.69%)

PZZA Papa John's
$99.32 /

+1.65 (+1.69%)

PZZA Papa John's
$99.32 /

+1.65 (+1.69%)

Recommendations
Silk Road Medical price target raised to $58 from $50 at Citi » 06:33
08/06/20
08/06
06:33
08/06/20
06:33
SILK

Silk Road Medical

$49.96 /

+1.61 (+3.33%)

Citi analyst Joanne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SILK Silk Road Medical
$49.96 /

+1.61 (+3.33%)

SILK Silk Road Medical
$49.96 /

+1.61 (+3.33%)

07/09/20
Fly Intel: Top five analyst initiations
07/09/20 SVB Leerink
Silk Road Medical initiated with an Outperform at SVB Leerink
05/27/20 Citi
Silk Road Medical initiated with a Buy at Citi
12/18/19 Stifel
Stifel says Silk Road TCAR data 'highly-encouraging' for boosting TCAR awareness
SILK Silk Road Medical
$49.96 /

+1.61 (+3.33%)

  • 06
    May
  • 09
    Aug
Earnings
National Vision reports Q2 adjusted EPS (41c), consensus (50c) » 06:32
08/06/20
08/06
06:32
08/06/20
06:32
EYE

National Vision

$34.02 /

+0.34 (+1.01%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EYE National Vision
$34.02 /

+0.34 (+1.01%)

EYE National Vision
$34.02 /

+0.34 (+1.01%)

06/10/20 Citi
National Vision price target raised to $36 from $31 at Citi
06/09/20 Wells Fargo
National Vision price target raised to $36 from $28 at Wells Fargo
05/08/20 Guggenheim
National Vision price target lowered to $35 from $45 at Guggenheim
04/17/20 Barclays
National Vision price target lowered to $28 from $44 at Barclays
EYE National Vision
$34.02 /

+0.34 (+1.01%)

  • 08
    Aug
EYE National Vision
$34.02 /

+0.34 (+1.01%)

Recommendations
Progyny price target raised to $32 from $28 at Citi » 06:32
08/06/20
08/06
06:32
08/06/20
06:32
PGNY

Progyny

$27.55 /

+0.33 (+1.21%)

Citi analyst Ralph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PGNY Progyny
$27.55 /

+0.33 (+1.21%)

PGNY Progyny
$27.55 /

+0.33 (+1.21%)

07/01/20 SVB Leerink
SVB Leerink bullish on Progyny, initiates with an Outperform
07/01/20 SVB Leerink
Progyny initiated with an Outperform at SVB Leerink
06/02/20 Guggenheim
Guggenheim starts Progyny at Buy, sees opportunity in pullback
06/02/20 Guggenheim
Progyny initiated with a Buy at Guggenheim
PGNY Progyny
$27.55 /

+0.33 (+1.21%)

  • 25
    Oct
PGNY Progyny
$27.55 /

+0.33 (+1.21%)

Recommendations
Nevro price target raised to $160 from $137 at Citi » 06:31
08/06/20
08/06
06:31
08/06/20
06:31
NVRO

Nevro

$137.38 /

+5.27 (+3.99%)

Citi analyst Joanne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$137.38 /

+5.27 (+3.99%)

NVRO Nevro
$137.38 /

+5.27 (+3.99%)

06/18/20 Morgan Stanley
Nevro price target raised to $145 from $135 at Morgan Stanley
06/08/20 UBS
Nevro upgraded to Neutral from Sell at UBS
05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
NVRO Nevro
$137.38 /

+5.27 (+3.99%)

  • 02
    Apr
NVRO Nevro
$137.38 /

+5.27 (+3.99%)

Recommendations
PPD, Inc. price target raised to $37 from $31 at Citi » 06:30
08/06/20
08/06
06:30
08/06/20
06:30
PPD

PPD, Inc.

$32.00 /

+1.1 (+3.56%)

Citi analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PPD PPD, Inc.
$32.00 /

+1.1 (+3.56%)

PPD PPD, Inc.
$32.00 /

+1.1 (+3.56%)

08/05/20 Credit Suisse
PPD, Inc. price target raised to $35 from $30 at Credit Suisse
06/04/20
Fly Intel: Top five analyst initiations
06/04/20 KeyBanc
PPD, Inc. initiated with an Overweight, $35 target at KeyBanc
06/03/20 KeyBanc
PPD, Inc. initiated with an Overweight at KeyBanc
PPD PPD, Inc.
$32.00 /

+1.1 (+3.56%)

  • 06
    Feb
PPD PPD, Inc.
$32.00 /

+1.1 (+3.56%)

PPD PPD, Inc.
$32.00 /

+1.1 (+3.56%)

Earnings
Amneal Pharmaceuticals backs FY20 adjusted EPS view 45c-60c, consensus 56c » 06:29
08/06/20
08/06
06:29
08/06/20
06:29
AMRX

Amneal Pharmaceuticals

$5.26 /

+0.59 (+12.63%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

07/27/20 Goldman Sachs
Amneal Pharmaceuticals initiated with a Sell at Goldman Sachs
05/12/20 Guggenheim
Amneal Pharmaceuticals upgraded to Neutral amid generics recovery at Guggenheim
05/12/20 Guggenheim
Amneal Pharmaceuticals upgraded to Neutral from Sell at Guggenheim
01/08/20 Guggenheim
Horizon Therapeutics named Guggenheim's best Emerging Pharma idea for 2020
AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

Recommendations
Fiverr price target raised to $144 from $67 at JMP Securities » 06:28
08/06/20
08/06
06:28
08/06/20
06:28
FVRR

Fiverr

$122.87 /

+18.83 (+18.10%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FVRR Fiverr
$122.87 /

+18.83 (+18.10%)

FVRR Fiverr
$122.87 /

+18.83 (+18.10%)

08/05/20 Needham
Needham raises Fiverr price target to $155 as business is 'exploding'
08/05/20 Needham
Fiverr price target raised to $155 from $55 at Needham
07/17/20
Fly Intel: Top five analyst downgrades
07/17/20 JPMorgan
Fiverr downgraded to Neutral after 169% rally at JPMorgan
FVRR Fiverr
$122.87 /

+18.83 (+18.10%)

  • 29
    May
FVRR Fiverr
$122.87 /

+18.83 (+18.10%)

FVRR Fiverr
$122.87 /

+18.83 (+18.10%)

Upgrade
Jazz Pharmaceuticals upgraded to Overweight from Equal Weight at Morgan Stanley » 06:28
08/06/20
08/06
06:28
08/06/20
06:28
JAZZ

Jazz Pharmaceuticals

$122.27 /

+12.045 (+10.93%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JAZZ Jazz Pharmaceuticals
$122.27 /

+12.045 (+10.93%)

JAZZ Jazz Pharmaceuticals
$122.27 /

+12.045 (+10.93%)

06:26 Today Morgan Stanley
Searching... upgraded to Overweight from Equal Weight at Morgan Stanley
07/30/20 Oppenheimer
Avadel Pharmaceuticals initiated with an Outperform at Oppenheimer
07/28/20 Wolfe Research
Jazz Pharmaceuticals upgraded to Outperform from Peer Perform at Wolfe Research
07/23/20 Jefferies
Xywav launch could be key catalyst for Jazz shares, says Jefferies
JAZZ Jazz Pharmaceuticals
$122.27 /

+12.045 (+10.93%)

JAZZ Jazz Pharmaceuticals
$122.27 /

+12.045 (+10.93%)

Earnings
Amneal Pharmaceuticals reports Q2 adjusted EPS 13c, consensus 10c » 06:28
08/06/20
08/06
06:28
08/06/20
06:28
AMRX

Amneal Pharmaceuticals

$5.26 /

+0.59 (+12.63%)

Reports Q2 revenue $465M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

07/27/20 Goldman Sachs
Amneal Pharmaceuticals initiated with a Sell at Goldman Sachs
05/12/20 Guggenheim
Amneal Pharmaceuticals upgraded to Neutral amid generics recovery at Guggenheim
05/12/20 Guggenheim
Amneal Pharmaceuticals upgraded to Neutral from Sell at Guggenheim
01/08/20 Guggenheim
Horizon Therapeutics named Guggenheim's best Emerging Pharma idea for 2020
AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

Recommendations
Arista Networks selloff an 'attractive buying opportunity,' says Citi » 06:28
08/06/20
08/06
06:28
08/06/20
06:28
ANET

Arista Networks

$235.28 /

-28.95 (-10.96%)

Citi analyst Jim Suva…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANET Arista Networks
$235.28 /

-28.95 (-10.96%)

ANET Arista Networks
$235.28 /

-28.95 (-10.96%)

08/05/20 Wells Fargo
Arista Networks price target raised to $230 from $215 at Wells Fargo
07/24/20 Wolfe Research
Arista Networks initiated with a Peer Perform at Wolfe Research
05/06/20 Wells Fargo
Arista Networks price target raised to $215 from $205 at Wells Fargo
05/06/20 Nomura Instinet
Arista Networks price target raised to $190 from $180 at Nomura Instinet
ANET Arista Networks
$235.28 /

-28.95 (-10.96%)

ANET Arista Networks
$235.28 /

-28.95 (-10.96%)

Earnings
Syneos Health sees FY20 adjusted EPS $3.16-$3.38, consensus $2.98 » 06:27
08/06/20
08/06
06:27
08/06/20
06:27
SYNH

Syneos Health

$65.20 /

+0.43 (+0.66%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

07/16/20 SunTrust
Syneos Health price target raised to $74 from $66 at SunTrust
04/03/20 Mizuho
Syneos Health price target lowered to $42 from $56 at Mizuho
04/02/20 Credit Suisse
Syneos Health price target lowered to $62 from $72 at Credit Suisse
03/30/20 Goldman Sachs
Syneos Health downgraded to Neutral from Buy at Goldman Sachs
SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

Earnings
Ares Commercial reports Q2 core EPS 32c, consensus 25c » 06:26
08/06/20
08/06
06:26
08/06/20
06:26
ACRE

Ares Commercial

$9.23 /

+0.205 (+2.27%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACRE Ares Commercial
$9.23 /

+0.205 (+2.27%)

ACRE Ares Commercial
$9.23 /

+0.205 (+2.27%)

06/30/20
Fly Intel: Top five analyst upgrades
06/29/20 Keefe Bruyette
Keefe Bruyette upgrades Ares Commercial to Outperform, likes 14.8% yield
06/29/20 Keefe Bruyette
Ares Commercial upgraded to Outperform from Market Perform at Keefe Bruyette
04/27/20 Credit Suisse
Ares Commercial price target lowered to $9 from $17.50 at Credit Suisse
ACRE Ares Commercial
$9.23 /

+0.205 (+2.27%)

  • 23
    Jan
Earnings
Syneos Health reports Q2 adjusted EPS 58c, consensus 48c » 06:26
08/06/20
08/06
06:26
08/06/20
06:26
SYNH

Syneos Health

$65.20 /

+0.43 (+0.66%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

07/16/20 SunTrust
Syneos Health price target raised to $74 from $66 at SunTrust
04/03/20 Mizuho
Syneos Health price target lowered to $42 from $56 at Mizuho
04/02/20 Credit Suisse
Syneos Health price target lowered to $62 from $72 at Credit Suisse
03/30/20 Goldman Sachs
Syneos Health downgraded to Neutral from Buy at Goldman Sachs
SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

Recommendations
Karuna Therapeutics price target lowered to $130 from $140 at H.C. Wainwright » 06:25
08/06/20
08/06
06:25
08/06/20
06:25
KRTX

Karuna Therapeutics

/

+

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRTX Karuna Therapeutics
/

+

KRTX Karuna Therapeutics
/

+

06/24/20 Oppenheimer
Karuna Therapeutics price target raised to $135 from $125 at Oppenheimer
06/02/20 Wedbush
Karuna Therapeutics price target raised to $126 from $117 at Wedbush
06/01/20 Goldman Sachs
Karuna price target raised to $131 from $115 at Goldman Sachs
05/31/20 Stifel
Karuna schizophrenia drug has blockbuster potential, says Stifel
KRTX Karuna Therapeutics
/

+

  • 23
    Jan
  • 21
    Nov
Downgrade
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley » 06:25
08/06/20
08/06
06:25
08/06/20
06:25
PAHC

Phibro Animal Health

$23.85 /

+0.4 (+1.71%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PAHC Phibro Animal Health
$23.85 /

+0.4 (+1.71%)

PAHC Phibro Animal Health
$23.85 /

+0.4 (+1.71%)

02/06/20 Gabelli
Phibro Animal Health downgraded to Hold on valuation at Gabelli
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold from Buy at Gabelli
01/28/20 Barclays
Barclays upgrades Phibro to Equal Weight after underperformance
01/28/20 Barclays
Phibro Animal Health upgraded to Equal Weight from Underweight at Barclays
PAHC Phibro Animal Health
$23.85 /

+0.4 (+1.71%)

Upgrade
Infinera upgraded to Buy ahead of ICE6 delivery at Rosenblatt » 06:25
08/06/20
08/06
06:25
08/06/20
06:25
INFN

Infinera

$7.80 /

-0.315 (-3.88%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INFN Infinera
$7.80 /

-0.315 (-3.88%)

INFN Infinera
$7.80 /

-0.315 (-3.88%)

05:21 Today Rosenblatt
Infinera upgraded to Buy from Neutral at Rosenblatt
08/03/20 Jefferies
Jefferies says Ciena could take share from Huawei in Europe faster than expected
07/28/20 Raymond James
Corning results provide read-through to optical names, says Raymond James
07/24/20 Wolfe Research
Infinera initiated with an Underperform at Wolfe Research
INFN Infinera
$7.80 /

-0.315 (-3.88%)

INFN Infinera
$7.80 /

-0.315 (-3.88%)

INFN Infinera
$7.80 /

-0.315 (-3.88%)

Earnings
Titan International reports Q2 EPS (8c), consensus (36c) » 06:25
08/06/20
08/06
06:25
08/06/20
06:25
TWI

Titan International

$1.61 /

+0.01 (+0.63%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWI Titan International
$1.61 /

+0.01 (+0.63%)

TWI Titan International
$1.61 /

+0.01 (+0.63%)

Upgrade
GoDaddy upgraded to Strong Buy from Outperform at Raymond James » 06:24
08/06/20
08/06
06:24
08/06/20
06:24
GDDY

GoDaddy

$74.46 /

+1.125 (+1.53%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GDDY GoDaddy
$74.46 /

+1.125 (+1.53%)

GDDY GoDaddy
$74.46 /

+1.125 (+1.53%)

06:21 Today Raymond James
GoDaddy upgraded to Strong Buy at Raymond James after 'solid' Q2 results
04:46 Today Raymond James
GoDaddy upgraded to Strong Buy from Outperform at Raymond James
04:42 Today JPMorgan
GoDaddy upgraded to Overweight from Neutral at JPMorgan
07/16/20 Barclays
GoDaddy risk/reward attractive at current share levels, says Barclays
GDDY GoDaddy
$74.46 /

+1.125 (+1.53%)

GDDY GoDaddy
$74.46 /

+1.125 (+1.53%)

GDDY GoDaddy
$74.46 /

+1.125 (+1.53%)

Earnings
State Auto Financial reports Q2 EPS (59c), consensus (76c) » 06:24
08/06/20
08/06
06:24
08/06/20
06:24
STFC

State Auto Financial

$16.04 /

+0.8 (+5.25%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STFC State Auto Financial
$16.04 /

+0.8 (+5.25%)

STFC State Auto Financial
$16.04 /

+0.8 (+5.25%)

07/16/20 Sidoti
State Auto Financial initiated with a Neutral at Sidoti
05/19/20 Keefe Bruyette
State Auto Financial price target lowered to $24 from $28 at Keefe Bruyette
STFC State Auto Financial
$16.04 /

+0.8 (+5.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.